Skip to main content
SpringerLink
Log in

Physical Therapy and Orthotic Devices

  • Chapter
Muscular Dystrophy

Abstract

Similarities in the clinical presentation of the various types of muscular dystrophy allow the use of common principles of clinical management and intervention to provide optimal comprehensive care with the coordinated expertise of a multidisciplinary team. Anticipatory physical therapy (PT) management is based upon an understanding of the pathokinesiology of each type of MD, an understanding of the progression of the pathokinesiology overtime, individual evaluation within the context of each individual’s life and goals, and provision of consistent, preventative management across the lifespan in order to minimize the clinical and functional impact of the diagnosis and to optimize quality of life. We are now entering an exciting new era, in which the natural histories of neuromuscular disorders are changing and improving based on improved medical care and management, and in which actual disease modifying treatments are emerging. PT management may for the first time contribute to improvement and recovery in individuals with muscle diseases, in addition to using prospective anticipatory care to manage impairments and optimize function and participation. In this new era, it will remain important to understand and continue to use optimal principles of intervention in comprehensive, anticipatory, preventative management and to optimize the benefits of disease modifying treatments as they emerge.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vignos PJ. Rehabilitation in progressive muscular dystrophy. New Haven: Licht; 1968.

    Google Scholar 

  2. Dubowitz V. Progressive muscular dystrophy: prevention of deformities. Clin Pediatr (Phila). 1964;12:323–8.

    Google Scholar 

  3. Dubowitz V. Muscle disorders in childhood. 2nd ed. London: Saunders; 1995.

    Google Scholar 

  4. Bushby KM, Pollitt C, Johnson MA, Rogers MT, Chinnery PF. Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord. 1998;8(8):574–9.

    CAS  PubMed  Google Scholar 

  5. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.

    PubMed  Google Scholar 

  6. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.

    CAS  PubMed  Google Scholar 

  7. Bushby KM. The muscular dystrophies. Baillieres Clin Neurol. 1994;3(2):407–30.

    CAS  PubMed  Google Scholar 

  8. Bushby KM, Gardner-Medwin D, Nicholson LV, et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol. 1993;240(2):105–12.

    CAS  PubMed  Google Scholar 

  9. Bushby KM, Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J Neurol. 1993;240(2):98–104.

    CAS  PubMed  Google Scholar 

  10. Guglieri M, Straub V, Bushby K, Lochmuller H. Limb-girdle muscular dystrophies. Curr Opin Neurol. 2008;21(5):576–84.

    CAS  PubMed  Google Scholar 

  11. Dubowitz V. Prevention of deformities. Isr J Med Sci. 1977;13(2):183–8.

    CAS  PubMed  Google Scholar 

  12. Wang CH, Bonnemann CG, Rutkowski A, et al. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010;25(12):1559–81.

    PubMed  Google Scholar 

  13. Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group. Phys Ther. 1994;74(3):253–63.

    CAS  PubMed  Google Scholar 

  14. Roy L, Gibson DA. Pseudohypertrophic muscular dystrophy and its surgical management: review of 30 patients. Can J Surg. 1970;13(1):13–21.

    CAS  PubMed  Google Scholar 

  15. Kilmer DD, Abresch RT, McCrory MA, et al. Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S131–9.

    CAS  PubMed  Google Scholar 

  16. McDonald CM, Abresch RT, Carter GT, Fowler Jr WM, Johnson ER, Kilmer DD. Profiles of neuromuscular diseases. Becker’s muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S93–103.

    CAS  PubMed  Google Scholar 

  17. McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S70–92.

    CAS  PubMed  Google Scholar 

  18. McDonald CM, Johnson ER, Abresch RT, Carter GT, Fowler Jr WM, Kilmer DD. Profiles of neuromuscular diseases. Limb-girdle syndromes. Am J Phys Med Rehabil. 1995;74(5 Suppl):S117–30.

    CAS  PubMed  Google Scholar 

  19. Fowler Jr WM. Rehabilitation management of muscular dystrophy and related disorders: II. Comprehensive care. Arch Phys Med Rehabil. 1982;63(7):322–8.

    PubMed  Google Scholar 

  20. Miller G, Dunn N. An outline of the management and prognosis of Duchenne muscular dystrophy in Western Australia. Aust Paediatr J. 1982;18(4):277–82.

    CAS  PubMed  Google Scholar 

  21. Scott OM, Hyde SA, Goddard C, Dubowitz V. Prevention of deformity in Duchenne muscular dystrophy. A prospective study of passive stretching and splintage. Physiotherapy. 1981;67(6):177–80.

    CAS  PubMed  Google Scholar 

  22. Scott OM, Hyde SA, Goddard C, Jones R, Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy. 1981;67(6):174–6.

    CAS  PubMed  Google Scholar 

  23. Hyde SA, Scott OM, Goddard CM, Dubowitz V. Prolongation of ambulation in Duchenne muscular dystrophy by appropriate orthoses. Physiotherapy. 1982;68(4):105–8.

    CAS  PubMed  Google Scholar 

  24. Johnson ER, Fowler Jr WM, Lieberman JS. Contractures in neuromuscular disease. Arch Phys Med Rehabil. 1992;73(9):807–10.

    CAS  PubMed  Google Scholar 

  25. Cherry DB. Review of physical therapy alternatives for reducing muscle contracture. Phys Ther. 1980;60(7):877–81.

    CAS  PubMed  Google Scholar 

  26. Harris SE, Cherry DB. Childhood progressive muscular dystrophy and the role of physical therapy. Phys Ther. 1974;54(1):4–12.

    CAS  PubMed  Google Scholar 

  27. Johnson LB, Florence JM, Abresch RT. Physical therapy evaluation and management in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012;23(3):633–51.

    PubMed  Google Scholar 

  28. Stuberg WA. Muscular dystrophy and spinal muscular atrophy. In: Campbell SK, et al, editors. Physical therapy for children. St. Louis: Elsevier Saunders; 2012.

    Google Scholar 

  29. Gardner-Medwin D. Management of muscular dystrophy. Physiotherapy. 1977;63(2):46–51.

    CAS  PubMed  Google Scholar 

  30. Siegel IM. Pathomechanics of stance in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1972;53(9):403–6.

    CAS  PubMed  Google Scholar 

  31. Sutherland DH, Olshen R, Cooper L, et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981;23(1):3–22.

    CAS  PubMed  Google Scholar 

  32. Hsu JD, Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:122–5.

    PubMed  Google Scholar 

  33. Siegel IM, Weiss LA. Postural substitution in Duchenne’s muscular dystrophy. JAMA. 1982;247(5):584.

    CAS  PubMed  Google Scholar 

  34. Chyatte SB, Vignos Jr PJ, Watkins M. Early muscular dystrophy: differential patterns of weakness in Duchenne, limb-girdle and facioscapulohumeral types. Arch Phys Med Rehabil. 1966;47(8):499–503.

    CAS  PubMed  Google Scholar 

  35. Siegel IM. Scoliosis in muscular dystrophy. Some comments about diagnosis, observations on prognosis, and suggestions for therapy. Clin Orthop Relat Res. 1973;93:235–8.

    PubMed  Google Scholar 

  36. Archibald KC, Vignos Jr PJ. A study of contractures in muscular dystrophy. Arch Phys Med Rehabil. 1959;40(4):150–7.

    CAS  PubMed  Google Scholar 

  37. Johnson EW, Kennedy JH. Comprehensive management of Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1971;52(3):110–4.

    CAS  PubMed  Google Scholar 

  38. Iannaccone ST, Russman BS, Browne RH, Buncher CR, White M, Samaha FJ. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol. 2000;15(2):97–101.

    CAS  PubMed  Google Scholar 

  39. Bodor M, McDonald CM. Why short stature is beneficial in Duchenne muscular dystrophy. Muscle Nerve. 2013;48(3):336–42.

    PubMed  Google Scholar 

  40. Bushby K. Diagnosis and management of the limb girdle muscular dystrophies. Pract Neurol. 2009;9(6):314–23.

    PubMed  Google Scholar 

  41. Janssen BH, Voet NB, Nabuurs CI, et al. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. PLoS One. 2014;9(1):e85416.

    PubMed Central  PubMed  Google Scholar 

  42. Bergsma A, Murgia A, Cup EH, Verstegen PP, Meijer K, de Groot IJ. Upper extremity kinematics and muscle activation patterns in subjects with facioscapulohumeral dystrophy. Arch Phys Med Rehabil. 2014;95(9):1731–41.

    PubMed  Google Scholar 

  43. Bergsma A, Cup EH, Geurts AC, de Groot IJ. Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review. Disabil Rehabil. 2014;7:1–16.

    Google Scholar 

  44. Vignos Jr PJ, Spencer Jr GE, Archibald KC. Management of progressive muscular dystrophy in childhood. JAMA. 1963;184:89–96.

    PubMed  Google Scholar 

  45. Vignos Jr PJ. Physical models of rehabilitation in neuromuscular disease. Muscle Nerve. 1983;6(5):323–38.

    PubMed  Google Scholar 

  46. Johnson EW. Controversies about Duchenne muscular dystrophy. Dev Med Child Neurol. 1980;22(3):401–2.

    CAS  PubMed  Google Scholar 

  47. King W, Pandya S. Physical therapy & FSHD—a guide for patients and physical therapists. Lexington: FSH Society; 2009.

    Google Scholar 

  48. Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group. Neurology. 1994;44(3 Pt 1):442–6.

    CAS  PubMed  Google Scholar 

  49. Kissel JT. Facioscapulohumeral dystrophy. Semin Neurol. 1999;19(1):35–43.

    CAS  PubMed  Google Scholar 

  50. Statland JM, McDermott MP, Heatwole C, et al. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2013;23(4):306–12.

    PubMed Central  PubMed  Google Scholar 

  51. Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle. 2014;4:12.

    PubMed Central  PubMed  Google Scholar 

  52. Emery AE. Emery-Dreifuss muscular dystrophy and other related disorders. Br Med Bull. 1989;45(3):772–87.

    CAS  PubMed  Google Scholar 

  53. Emery AE. Emery-Dreifuss muscular dystrophy—a 40 year retrospective. Neuromuscul Disord. 2000;10(4–5):228–32.

    CAS  PubMed  Google Scholar 

  54. Merlini L. Selectivity of muscle sparing in Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2009;19(7):500–1.

    PubMed  Google Scholar 

  55. Vignos PJ, Wagner MB, Karlinchak B, Katirji B. Evaluation of a program for long-term treatment of Duchenne muscular dystrophy. Experience at the University Hospitals of Cleveland. J Bone Joint Surg Am. 1996;78(12):1844–52.

    CAS  PubMed  Google Scholar 

  56. Kishnani PS, Steiner RD, Bali D, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8(5):267–88.

    PubMed Central  PubMed  Google Scholar 

  57. Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027–49.

    PubMed  Google Scholar 

  58. World Health Organization. International classification of functioning, disability, and health (ICF). Geneva: World Health Organization; 2001.

    Google Scholar 

  59. Carter GT, Weiss MD, Chamberlain JR, et al. Aging with muscular dystrophy: pathophysiology and clinical management. Phys Med Rehabil Clin N Am. 2010;21(2):429–50.

    PubMed  Google Scholar 

  60. Mercuri E, Mayhew A, Muntoni F, et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord. 2008;18(11):894–903.

    CAS  PubMed  Google Scholar 

  61. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186–97.

    CAS  PubMed  Google Scholar 

  62. Haley SM, Coster WJ, Ludlow LH, et al. The pediatric evaluation of disability inventory. Boston: Center for Rehabilitation Effectiveness, Boston University; 1992.

    Google Scholar 

  63. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126–39.

    CAS  PubMed  Google Scholar 

  64. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.

    CAS  PubMed  Google Scholar 

  65. Brooke MH, Miller R. Fatigue testing. Muscle Nerve. 1990;13(Suppl):S35–7.

    PubMed  Google Scholar 

  66. Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci. 2013;331(1–2):102–7.

    CAS  PubMed  Google Scholar 

  67. McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357–68.

    PubMed Central  PubMed  Google Scholar 

  68. McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve. 2013;48(3):343–56.

    Google Scholar 

  69. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6–18.

    CAS  PubMed  Google Scholar 

  70. Ottenbacher KJ, Msall ME, Lyon NR, Duffy LC, Granger CV, Braun S. Interrater agreement and stability of the Functional Independence Measure for Children (WeeFIM): use in children with developmental disabilities. Arch Phys Med Rehabil. 1997;78(12):1309–15.

    CAS  PubMed  Google Scholar 

  71. Lerman JA, Sullivan E, Haynes RJ. The Pediatric Outcomes Data Collection Instrument (PODCI) and functional assessment in patients with adolescent or juvenile idiopathic scoliosis and congenital scoliosis or kyphosis. Spine (Phila Pa 1976). 2002;27(18):2052–7. Discussion 2057–8.

    Google Scholar 

  72. Lerman JA, Sullivan E, Barnes DA, Haynes RJ. The Pediatric Outcomes Data Collection Instrument (PODCI) and functional assessment of patients with unilateral upper extremity deficiencies. J Pediatr Orthop. 2005;25(3):405–7.

    PubMed  Google Scholar 

  73. Lee KM, Chung CY, Park MS, et al. Level of improvement determined by PODCI is related to parental satisfaction after single-event multilevel surgery in children with cerebral palsy. J Pediatr Orthop. 2010;30(4):396–402.

    PubMed  Google Scholar 

  74. Klepper SE. Measures of pediatric function: Child Health Assessment Questionnaire (C-HAQ), Juvenile Arthritis Functional Assessment Scale (JAFAS), Pediatric Outcomes Data Collection Instrument (PODCI), and Activities Scale for Kids (ASK). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S371–82.

    Google Scholar 

  75. Gates PE, Otsuka NY, Sanders JO, McGee-Brown J. Relationship between parental PODCI questionnaire and School Function Assessment in measuring performance in children with CP. Dev Med Child Neurol. 2008;50(9):690–5.

    PubMed  Google Scholar 

  76. Gates PE, Campbell SR. Effects of age, sex, and comorbidities on the Pediatric Outcomes Data Collection Instrument (PODCI) in the general population. J Pediatr Orthop. 2015;35(2):203–9.

    PubMed Central  PubMed  Google Scholar 

  77. Ward DS, Bar-Or O. Use of the Borg scale in exercise prescription for overweight youth. Can J Sport Sci. 1990;15(2):120–5.

    CAS  PubMed  Google Scholar 

  78. Wilson RC, Jones PW. Long-term reproducibility of Borg scale estimates of breathlessness during exercise. Clin Sci (Lond). 1991;80(4):309–12.

    CAS  Google Scholar 

  79. Hommerding PX, Donadio MV, Paim TF, Marostica PJ. The Borg scale is accurate in children and adolescents older than 9 years with cystic fibrosis. Respir Care. 2010;55(6):729–33.

    PubMed  Google Scholar 

  80. Florence JM, Pandya S, King WM, et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther. 1992;72(2):115–22. Discussion 122–116.

    CAS  PubMed  Google Scholar 

  81. Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve. 2001;24(6):787–93.

    CAS  PubMed  Google Scholar 

  82. Angelini C, Semplicini C, Tonin P, et al. Progress in enzyme replacement therapy in glycogen storage disease type II. Ther Adv Neurol Disord. 2009;2(3):143–53.

    PubMed Central  PubMed  Google Scholar 

  83. Angelini C, Semplicini C, Ravaglia S, et al. New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. Muscle Nerve. 2012;45(6):831–4.

    PubMed  Google Scholar 

  84. Hagemans ML, Laforet P, Hop WJ, et al. Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale. Neuromuscul Disord. 2007;17(7):537–43.

    CAS  PubMed  Google Scholar 

  85. McColl MA, Paterson M, Davies D, Doubt L, Law M. Validity and community utility of the Canadian Occupational Performance Measure. Can J Occup Ther. 2000;67(1):22–30.

    CAS  PubMed  Google Scholar 

  86. Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990;57(2):82–7.

    CAS  PubMed  Google Scholar 

  87. Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond). 1989;76(3):277–82.

    CAS  Google Scholar 

  88. Mazzone ES, Messina S, Vasco G, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord. 2009;19(7):458–61.

    CAS  PubMed  Google Scholar 

  89. Mazzone E, Martinelli D, Berardinelli A, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2010;20(11):712–6.

    PubMed  Google Scholar 

  90. Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2011;53(6):535–42.

    PubMed  Google Scholar 

  91. Ergul Y, Ekici B, Nisli K, et al. Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy. J Paediatr Child Health. 2012;48(7):610–6.

    PubMed  Google Scholar 

  92. Mayhew AG, Cano SJ, Scott E, et al. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1046–52.

    PubMed  Google Scholar 

  93. De Sanctis R, Pane M, Sivo S, et al. Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25(1):14–8.

    PubMed  Google Scholar 

  94. Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol. 2002;55(1):67–76.

    PubMed  Google Scholar 

  95. Berard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463–70.

    PubMed  Google Scholar 

  96. Young NL, Williams JI, Yoshida KK, Wright JG. Measurement properties of the activities scale for kids. J Clin Epidemiol. 2000;53(2):125–37.

    CAS  PubMed  Google Scholar 

  97. Young NL, Varni JW, Snider L, et al. The Internet is valid and reliable for child-report: an example using the Activities Scale for Kids (ASK) and the Pediatric Quality of Life Inventory (PedsQL). J Clin Epidemiol. 2009;62(3):314–20.

    PubMed  Google Scholar 

  98. Main M, Kairon H, Mercuri E, Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003;7(4):155–9.

    PubMed  Google Scholar 

  99. Krosschell KJ, Maczulski JA, Crawford TO, Scott C, Swoboda KJ. A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy. Neuromuscul Disord. 2006;16(7):417–26.

    PubMed Central  PubMed  Google Scholar 

  100. van Capelle CI, van der Beek NA, de Vries JM, et al. The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients. J Inherit Metab Dis. 2012;35(2):317–23.

    PubMed Central  PubMed  Google Scholar 

  101. McDonald CM, Widman LM, Walsh DD, Walsh SA, Abresch RT. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2005;86(4):802–8.

    PubMed  Google Scholar 

  102. McDonald CM, Widman L, Abresch RT, Walsh SA, Walsh DD. Utility of a step activity monitor for the measurement of daily ambulatory activity in children. Arch Phys Med Rehabil. 2005;86(4):793–801.

    PubMed  Google Scholar 

  103. Steffensen B, Hyde S, Lyager S, Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int. 2001;6(3):119–34.

    CAS  PubMed  Google Scholar 

  104. Piper MC, Darrah J. Motor assessment of the developing infant. Philadelphia: W. B. Saunders; 1994.

    Google Scholar 

  105. Russell D, Rosenbaum P, Avery L, Lane M. Gross motor function measure (GMFM-66 & GMFM-88) user’s manual. London: Mac Keith; 2002.

    Google Scholar 

  106. Folio MR, Fewell R. Peabody developmental motor scales. 2nd ed. Austin: Pro-Ed; 2000.

    Google Scholar 

  107. Bruininks R. Bruininks-Oseretsky test of motor proficiency. 2nd ed. Minneapolis: Pearson; 2005.

    Google Scholar 

  108. Mayhew A, Mazzone ES, Eagle M, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55(11):1038–45.

    PubMed  Google Scholar 

  109. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.

    Google Scholar 

  110. Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66(8):271–3.

    CAS  PubMed  Google Scholar 

  111. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990;41(2):139–50.

    CAS  PubMed  Google Scholar 

  112. Krechel SW, Bildner J. CRIES: a new neonatal postoperative pain measurement score. Initial testing of validity and reliability. Paediatr Anaesth. 1995;5(1):53–61.

    CAS  PubMed  Google Scholar 

  113. Pasero CL. Using the Faces scale to assess pain. Am J Nurs. 1997;97(7):19–20.

    CAS  PubMed  Google Scholar 

  114. Ferrell BA, Stein WM, Beck JC. The Geriatric Pain Measure: validity, reliability and factor analysis. J Am Geriatr Soc. 2000;48(12):1669–73.

    CAS  PubMed  Google Scholar 

  115. McCaffery M. Choosing a faces pain scale. Nursing. 2002;32(5):68.

    PubMed  Google Scholar 

  116. O’Rourke D. The measurement of pain in infants, children, and adolescents: from policy to practice. Phys Ther. 2004;84(6):560–70.

    PubMed  Google Scholar 

  117. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–91.

    PubMed  Google Scholar 

  118. Tashjian RZ, Deloach J, Porucznik CA, Powell AP. Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2009;18(6):927–32.

    PubMed  Google Scholar 

  119. McDonald CM. Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am. 1998;9(1):187–211.

    CAS  PubMed  Google Scholar 

  120. Siegel IM. Plastic-molded knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1975;56(7):322.

    CAS  PubMed  Google Scholar 

  121. Siegel IM. Prolongation of ambulation through early percutaneous tenotomy and bracing with plastic orthoses. Isr J Med Sci. 1977;13(2):192–6.

    CAS  PubMed  Google Scholar 

  122. Aprile I, Bordieri C, Gilardi A, et al. Balance and walking involvement in facioscapulohumeral dystrophy: a pilot study on the effects of custom lower limb orthoses. Eur J Phys Rehabil Med. 2013;49(2):169–78.

    CAS  PubMed  Google Scholar 

  123. Hyde SA, FlLytrup I, Glent S, et al. A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscul Disord. 2000;10(4–5):257–63.

    CAS  PubMed  Google Scholar 

  124. Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res. 2004;19(3):360–9.

    PubMed  Google Scholar 

  125. Ashmore CR, Lee YB, Summers P, Hitchcock L. Stretch-induced growth in chicken wing muscles: nerve-muscle interaction in muscular dystrophy. Am J Physiol. 1984;246(5 Pt 1):C378–84.

    CAS  PubMed  Google Scholar 

  126. Glanzman AM, Flickinger JM, Dholakia KH, Bonnemann CG, Finkel RS. Serial casting for the management of ankle contracture in Duchenne muscular dystrophy. Pediatr Phys Ther. 2011;23(3):275–9.

    PubMed  Google Scholar 

  127. Main M, Mercuri E, Haliloglu G, Baker R, Kinali M, Muntoni F. Serial casting of the ankles in Duchenne muscular dystrophy: can it be an alternative to surgery? Neuromuscul Disord. 2007;17(3):227–30.

    PubMed  Google Scholar 

  128. American Physical Therapy Association. Guide to physical therapy practice. Phys Ther. 2001;81(1).

    Google Scholar 

  129. Townsend EL, Tamhane H, Gross KD. Effects of AFO use on walking in boys with Duchenne muscular dystrophy: a pilot study. Pediatr Phys Ther. 2015;27(1):24–9.

    PubMed  Google Scholar 

  130. Chyatte SB, Long II C, Vignos Jr PJ. The balanced forearm orthosis in muscular dystrophy. Arch Phys Med Rehabil. 1965;46(9):633–6.

    CAS  PubMed  Google Scholar 

  131. Han JJ, Kurillo G, Abresch RT, de Bie E, Nicorici A, Bajcsy R. Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by Kinect. Muscle Nerve. 2015;51(2):168–75.

    PubMed  Google Scholar 

  132. Han JJ, Kurillo G, Abresch RT, Nicorici A, Bajcsy R. Validity, reliability, and sensitivity of a 3D vision sensor-based upper extremity reachable workspace evaluation in neuromuscular diseases. PLoS Curr. 2013;5.

    Google Scholar 

  133. Vignos Jr PJ, Archibald KC. Maintenance of ambulation in childhood muscular dystrophy. J Chronic Dis. 1960;12:273–90.

    PubMed  Google Scholar 

  134. Spencer Jr GE, Vignos Jr PJ. Bracing for ambulation in childhood progressive muscular dystrophy. Am J Orthop. 1962;44-A:234–42.

    Google Scholar 

  135. Vignos Jr PJ, Wagner MB, Kaplan JS, Spencer Jr GE. Predicting the success of reambulation in patients with Duchenne muscular dystrophy. J Bone Joint Surg Am. 1983;65(6):719–28.

    PubMed  Google Scholar 

  136. Bowker JH, Halpin PJ. Factors determining success in reambulation of the child with progressive muscular dystrophy. Orthop Clin North Am. 1978;9(2):431–6.

    CAS  PubMed  Google Scholar 

  137. Tardieu C, Lespargot A, Tabary C, Bret MD. For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol. 1988;30(1):3–10.

    CAS  PubMed  Google Scholar 

  138. Stuberg WA. Considerations related to weight-bearing programs in children with developmental disabilities. Phys Ther. 1992;72(1):35–40.

    CAS  PubMed  Google Scholar 

  139. Spencer Jr GE. Orthopaedic care of progressive muscular dystrophy. J Bone Joint Surg Am. 1967;49(6):1201–4.

    PubMed  Google Scholar 

  140. Alman BA, Raza SN, Biggar WD. Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy. J Bone Joint Surg Am. 2004;86-A(3):519–24.

    PubMed  Google Scholar 

  141. Brooke MH, Fenichel GM, Griggs RC, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39(4):475–81.

    CAS  PubMed  Google Scholar 

  142. Smith AD, Koreska J, Moseley CF. Progression of scoliosis in Duchenne muscular dystrophy. J Bone Joint Surg Am. 1989;71(7):1066–74.

    CAS  PubMed  Google Scholar 

  143. Siegel IM. Spinal stabilization in Duchenne muscular dystrophy: rationale and method. Muscle Nerve. 1982;5(5):417–8.

    CAS  PubMed  Google Scholar 

  144. Gardner-Medwin D. Controversies about Duchenne muscular dystrophy. (2) Bracing for ambulation. Dev Med Child Neurol. 1979;21(5):659–62.

    CAS  PubMed  Google Scholar 

  145. Kerr TP, Lin JP, Gresty MA, Morley T, Robb SA. Spinal stability is improved by inducing a lumbar lordosis in boys with Duchenne muscular dystrophy: a pilot study. Gait Posture. 2008;28(1):108–12.

    PubMed  Google Scholar 

  146. Kinali M, Main M, Eliahoo J, et al. Predictive factors for the development of scoliosis in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2007;11(3):160–6.

    CAS  PubMed  Google Scholar 

  147. Muntoni F, Bushby K, Manzur AY. Muscular dystrophy campaign funded workshop on management of scoliosis in Duchenne muscular dystrophy 24 January 2005, London, UK. Neuromuscul Disord. 2006;16(3):210–9.

    PubMed  Google Scholar 

  148. Rodillo EB, Fernandez-Bermejo E, Heckmatt JZ, Dubowitz V. Prevention of rapidly progressive scoliosis in Duchenne muscular dystrophy by prolongation of walking with orthoses. J Child Neurol. 1988;3(4):269–74.

    CAS  PubMed  Google Scholar 

  149. Siegel IM. The management of muscular dystrophy: a clinical review. Muscle Nerve. 1978;1(6):453–60.

    CAS  PubMed  Google Scholar 

  150. Wilkins KE, Gibson DA. The patterns of spinal deformity in Duchenne muscular dystrophy. J Bone Joint Surg Am. 1976;58(1):24–32.

    CAS  PubMed  Google Scholar 

  151. Case LE. Physical therapy management of the spine in Duchenne muscular dystrophy. Postgraduate fellowship project, Postgraduate fellowship in pediatric physical and occupational therapy, University of North Carolina at Chapel Hill. 1985.

    Google Scholar 

  152. Johnson EW, Yarnell SK. Hand dominance and scoliosis in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1976;57(10):462–4.

    CAS  PubMed  Google Scholar 

  153. Johnson EW, Walter J. Zeiter Lecture: pathokinesiology of Duchenne muscular dystrophy: implications for management. Arch Phys Med Rehabil. 1977;58(1):4–7.

    CAS  PubMed  Google Scholar 

  154. Gibson DA, Albisser AM, Koreska J. Role of the wheelchair in the management of the muscular dystrophy patient. Can Med Assoc J. 1975;113(10):964–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  155. Gibson DA, Wilkins KE. The management of spinal deformities in Duchenne muscular dystrophy. A new concept of spinal bracing. Clin Orthop Relat Res. 1975;108:41–51.

    PubMed  Google Scholar 

  156. Koreska J, Robertson D, Mills RH, Gibson DA, Albisser AM. Biomechanics of the lumbar spine and its clinical significance. Orthop Clin North Am. 1977;8(1):121–33.

    CAS  PubMed  Google Scholar 

  157. Werner BC, Skalsky AJ, McDonald CM, Han JJ. Convexity of scoliosis related to handedness in identical twin boys with Duchenne’s muscular dystrophy: a case report. Arch Phys Med Rehabil. 2008;89(10):2021–4.

    PubMed  Google Scholar 

  158. Bonsett CA. Prophylactic bracing in pseudohypertrophic muscular dystrophy (preliminary report) part I: patient experience. J Indiana State Med Assoc. 1975;68(3):181–4.

    CAS  PubMed  Google Scholar 

  159. Bonsett CA, Glancy JJ. Prophylactic bracing in pseudohypertrophic muscular dystrophy (preliminary report). Part II: the brace. J Indiana State Med Assoc. 1975;68(3):185–7.

    CAS  PubMed  Google Scholar 

  160. Brown JC, Zeller JL, Swank SM, Furumasu J, Warath SL. Surgical and functional results of spine fusion in spinal muscular atrophy. Spine. 1989;14(7):763–70.

    CAS  PubMed  Google Scholar 

  161. Bleck EE. Mobility of patients with Duchenne muscular dystrophy. Dev Med Child Neurol. 1979;21(6):823–4.

    CAS  PubMed  Google Scholar 

  162. Birnkrant DJ, Bushby KM, Amin RS, et al. The respiratory management of patients with Duchenne muscular dystrophy: a DMD care considerations working group specialty article. Pediatr Pulmonol. 2010;45(8):739–48.

    PubMed  Google Scholar 

  163. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456–65.

    PubMed  Google Scholar 

  164. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12(10):926–9.

    PubMed  Google Scholar 

  165. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624.

    Google Scholar 

  166. Fauroux B, Quijano-Roy S, Desguerre I, Khirani S. The value of respiratory muscle testing in children with neuromuscular disease. Chest. 2015;147(2):552–9.

    PubMed  Google Scholar 

  167. Topin N, Matecki S, Le Bris S, et al. Dose-dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord. 2002;12(6):576–83.

    PubMed  Google Scholar 

  168. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, The Netherlands. Neuromuscul Disord. 2003;13(2):166–72.

    CAS  PubMed  Google Scholar 

  169. Takano N, Honke K, Hasui M, Ohno I, Takemura H. A case of pacemaker implantation for complete atrioventricular block associated with Duchenne muscular dystrophy. No To Hattatsu. 1997;29(6):476–80.

    CAS  PubMed  Google Scholar 

  170. Cripe LH, Tobias JD. Cardiac considerations in the operative management of the patient with Duchenne or Becker muscular dystrophy. Paediatr Anaesth. 2013;23(9):777–84.

    PubMed  Google Scholar 

  171. Yilmaz A, Sechtem U. Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Heart. 2012;98(5):420–9.

    CAS  PubMed  Google Scholar 

  172. Vignos Jr PJ, Watkins MP. The effect of exercise in muscular dystrophy. JAMA. 1966;197(11):843–8.

    PubMed  Google Scholar 

  173. Houser CR, Johnson DM. Breathing exercises for children with pseudohypertrophic muscular dystrophy. Phys Ther. 1971;51(7):751–9.

    CAS  PubMed  Google Scholar 

  174. Fowler Jr WM, Taylor M. Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise. Arch Phys Med Rehabil. 1982;63(7):319–21.

    PubMed  Google Scholar 

  175. Valentine BA, Blue JT, Cooper BJ. The effect of exercise on canine dystrophic muscle. Ann Neurol. 1989;26(4):588.

    CAS  PubMed  Google Scholar 

  176. Armstrong RB, Warren GL, Warren JA. Mechanisms of exercise-induced muscle fibre injury. Sports Med. 1991;12(3):184–207.

    CAS  PubMed  Google Scholar 

  177. McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol. 1992;140(5):1097–109.

    CAS  PubMed Central  PubMed  Google Scholar 

  178. Hayes A, Lynch GS, Williams DA. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc R Soc Lond B Biol Sci. 1993;253(1336):19–25.

    CAS  Google Scholar 

  179. Lynch GS, Hayes A, Lam MH, Williams DA. The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres. Proc Biol Sci. 1993;253(1336):27–33.

    CAS  PubMed  Google Scholar 

  180. Brussee V, Tardif F, Tremblay JP. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord. 1997;7(8):487–92.

    CAS  PubMed  Google Scholar 

  181. Hayes A, Williams DA. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol. 1998;274(4 Pt 1):C1138–44.

    CAS  PubMed  Google Scholar 

  182. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord. 2002;12(10):975–83.

    PubMed  Google Scholar 

  183. Fowler Jr WM. Role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil. 2002;81(11 Suppl):S187–95.

    PubMed  Google Scholar 

  184. Abresch RT, Carter GT, Han JJ, McDonald CM. Exercise in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012;23(3):653–73.

    PubMed  Google Scholar 

  185. Markert CD, Case LE, Carter GT, Furlong PA, Grange RW. Exercise and Duchenne muscular dystrophy: where we have been and where we need to go. Muscle Nerve. 2012;45(5):746–51.

    PubMed  Google Scholar 

  186. Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol. 2010;10:56.

    PubMed Central  PubMed  Google Scholar 

  187. Abresch RT, Han JJ, Carter GT. Rehabilitation management of neuromuscular disease: the role of exercise training. J Clin Neuromuscul Dis. 2009;11(1):7–21.

    PubMed  Google Scholar 

  188. Rodillo E, Noble-Jamieson CM, Aber V, Heckmatt JZ, Muntoni F, Dubowitz V. Respiratory muscle training in Duchenne muscular dystrophy. Arch Dis Child. 1989;64(5):736–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  189. Gozal D, Thiriet P. Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception. Med Sci Sports Exerc. 1999;31(11):1522–7.

    CAS  PubMed  Google Scholar 

  190. Estrup C, Lyager S, Noeraa N, Olsen C. Effect of respiratory muscle training in patients with neuromuscular diseases and in normals. Respiration. 1986;50(1):36–43.

    CAS  PubMed  Google Scholar 

  191. Smith PE, Coakley JH, Edwards RH. Respiratory muscle training in Duchenne muscular dystrophy. Muscle Nerve. 1988;11(7):784–5.

    CAS  PubMed  Google Scholar 

  192. Aslan GK, Gurses HN, Issever H, Kiyan E. Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clin Rehabil. 2013;28(6):573–81.

    PubMed  Google Scholar 

  193. Peltekova I, Storr M. Case 1: back pain in a boy with Duchenne muscular dystrophy. Paediatr Child Health. 2014;19(6):299–300.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Physical Therapy, Department of Community and Family Medicine, Duke University Medical Center, DUMC, Box 104002, Durham, NC, 27708, USA

    Laura E. Case D.P.T., M.S., P.C.S., C./N.D.T.

Authors
  1. Laura E. Case D.P.T., M.S., P.C.S., C./N.D.T.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura E. Case D.P.T., M.S., P.C.S., C./N.D.T. .

Editor information

Editors and Affiliations

  1. Biosimilars Center of Excellence, Quintiles, Inc., Durham, North Carolina, USA

    Raymond A. Huml

Helpful Websites

Helpful Websites

Information About Diagnoses

Adaptive Equipment/Assistive Technology/Orthotic Intervention

Orthotic Intervention

Lifts, Bathing, and Bathrooming Equipment

Respiratory Care

Oximeters: http://www.pulseoximeter.org/

Car Seats for Fragile Infants

Standers

Wheelchairs/Mobility Devices

Cycling

Other

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Case, L.E. (2015). Physical Therapy and Orthotic Devices. In: Huml, R. (eds) Muscular Dystrophy. Springer, Cham. https://doi.org/10.1007/978-3-319-17362-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17362-7_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17361-0

  • Online ISBN: 978-3-319-17362-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation